MarketCap
Facebook
X
Telegram
AlloVir ROCE Ratio | ALVR
Annual ROCE Ratio AlloVir
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58.56 | 53.54 | 444.06 | -76.25 | -75.39 | -19.89 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 444.06 | -76.25 | 44.59 |
Quarterly ROCE Ratio AlloVir
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58.08 | -86.98 | -69.72 | -27.37 | 11.19 | 39.65 | 55.86 | 31.82 | -31.17 | -61.63 | -67.03 | -83.99 | -88.16 | -90.05 | -67.71 | -84.74 | -80.23 | -61.35 | -38.81 | -45.58 | -32.0 | -22.34 | -13.0 | 3.46 | 21.78 | -2.79 | - | 16.46 | 11.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 55.86 | -90.05 | -32.89 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Galecto
GLTO
|
-87.72 | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
-75.18 | - | 9357.83 % | $ 1.01 B |  USA |
 |
Graybug Vision
GRAY
|
348.16 | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
-63.97 | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-44.94 | - | 1.35 % | $ 17.8 M |  China |
 |
Hepion Pharmaceuticals
HEPA
|
-156.09 | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
-200.97 | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
-26.04 | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-104.22 | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
-40.7 | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
-84.35 | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
-52.85 | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-36.06 | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
1.34 | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-257.04 | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
162.48 | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
2841.81 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
77.47 | - | - | $ 1.2 B |  Australia |
|
BiomX
PHGE
|
6957.38 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-137.95 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-382.83 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
185.51 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-47.23 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-3.22 | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
-128.21 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
113.6 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
849.73 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-214.2 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-119.88 | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-146.87 | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-156.35 | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-33.79 | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-37.34 | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-199.35 | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
5.5 | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
13.56 | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-61.88 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
222.79 | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-261.49 | - | - | $ 26.8 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-141.18 | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-159.95 | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-129.64 | - | - | $ 13 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - |  Russia |
 |
Lyra Therapeutics
LYRA
|
289.47 | - | - | $ 24.9 M | USA |
 |
Завод ДИОД
DIOD
|
5.84 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-4.03 | - | - | - | Russia |